A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed)
A modified nucleoside which is present in the first position of the anticodon of tRNA-tyrosine, tRNA-histidine, tRNA-asparagine and tRNA-aspartic acid of many organisms. It is believed to play a role in the regulatory function of tRNA. Nucleoside Q can be further modified to nucleoside Q*, which has a mannose or galactose moiety linked to position 4 of its cyclopentenediol moiety.
The small RNA molecules, 73-80 nucleotides long, that function during translation (TRANSLATION, GENETIC) to align AMINO ACIDS at the RIBOSOMES in a sequence determined by the mRNA (RNA, MESSENGER). There are about 30 different transfer RNAs. Each recognizes a specific CODON set on the mRNA through its own ANTICODON and as aminoacyl tRNAs (RNA, TRANSFER, AMINO ACYL), each carries a specific amino acid to the ribosome to add to the elongating peptide chains.
Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES.
Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES.
Proteins involved in the transport of NUCLEOSIDES across cellular membranes.
A subtype of equilibrative nucleoside transporter proteins that is sensitive to inhibition by 4-nitrobenzylthioinosine.
Sulfhydryl analog of INOSINE that inhibits nucleoside transport across erythrocyte plasma membranes, and has immunosuppressive properties. It has been used similarly to MERCAPTOPURINE in the treatment of leukemia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p503)
An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1.
An enzyme that is found in mitochondria and in the soluble cytoplasm of cells. It catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside diphosphate, e.g., UDP, to form ADP and UTP. Many nucleoside diphosphates can act as acceptor, while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.6.
A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
Uridine is a nucleoside, specifically a derivative of pyrimidine, that is composed of a uracil molecule joined to a ribose sugar molecule through a β-N1 glycosidic bond, and has significant roles in RNA synthesis, energy transfer, and cell signaling.
A subtype of equilibrative nucleoside transporter proteins that is insensitive to inhibition by 4-nitrobenzylthioinosine.
An enzyme which catalyzes the hydrolysis of nucleoside triphosphates to nucleoside diphosphates. It may also catalyze the hydrolysis of nucleotide triphosphates, diphosphates, thiamine diphosphates and FAD. The nucleoside triphosphate phosphohydrolases I and II are subtypes of the enzyme which are found mostly in viruses.
A pyrimidine nucleoside that is composed of the base CYTOSINE linked to the five-carbon sugar D-RIBOSE.
Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
Pyrazolopyrimidine ribonucleosides isolated from Nocardia interforma. They are antineoplastic antibiotics with cytostatic properties.
Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another.
A family of nucleotide diphosphate kinases that play a role in a variety of cellular signaling pathways that effect CELL DIFFERENTIATION; CELL PROLIFERATION; and APOPTOSIS. They are considered multifunctional proteins that interact with a variety of cellular proteins and have functions that are unrelated to their enzyme activity.
Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template.
A class of sodium-independent nucleoside transporters that mediate the facilitative transport of NUCLEOSIDES.
A purine or pyrimidine base bonded to DEOXYRIBOSE.
Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule.
A subcomponent of complement C1, composed of six copies of three polypeptide chains (A, B, and C), each encoded by a separate gene (C1QA; C1QB; C1QC). This complex is arranged in nine subunits (six disulfide-linked dimers of A and B, and three disulfide-linked homodimers of C). C1q has binding sites for antibodies (the heavy chain of IMMUNOGLOBULIN G or IMMUNOGLOBULIN M). The interaction of C1q and immunoglobulin activates the two proenzymes COMPLEMENT C1R and COMPLEMENT C1S, thus initiating the cascade of COMPLEMENT ACTIVATION via the CLASSICAL COMPLEMENT PATHWAY.
A purine base and a fundamental unit of ADENINE NUCLEOTIDES.
Coronary vasodilator with some antiarrhythmic activity.
The rate dynamics in chemical or physical systems.
Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription.
An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids.
A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
Nucleosides containing arabinose as their sugar moiety.
A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
An enzyme that catalyzes reversibly the phosphorylation of deoxycytidine with the formation of a nucleoside diphosphate and deoxycytidine monophosphate. Cytosine arabinoside can also act as an acceptor. All natural nucleoside triphosphates, except deoxycytidine triphosphate, can act as donors. The enzyme is induced by some viruses, particularly the herpes simplex virus (HERPESVIRUS HOMINIS). EC 2.7.1.74.
Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P=O)O2 structure.
Pentosyltransferases that catalyze the reaction between a pyrimidine nucleoside and orthophosphate to form a free pyrimidine and ribose-5-phosphate.
Thymidine is a pyrimidine nucleoside, consisting of a thymine base linked to a deoxyribose sugar by a β-N1-glycosidic bond, which plays a crucial role in DNA replication and repair processes as one of the four nucleosides in DNA.
Nucleosides in which the base moiety is substituted with one or more sulfur atoms.
Nucleotides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy.
2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies.
An enzyme that catalyzes the transfer of ribose from uridine to orthophosphate, forming uracil and ribose 1-phosphate.
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.
A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process.
A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts.
Phosphate esters of THYMIDINE in N-glycosidic linkage with ribose or deoxyribose, as occurs in nucleic acids. (From Dorland, 28th ed, p1154)
A group of enzymes that catalyze the hydrolysis of diphosphate bonds in compounds such as nucleoside di- and tri-phosphates, and sulfonyl-containing anhydrides such as adenylylsulfate. (Enzyme Nomenclature, 1992) EC 3.6.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.
The phosphate esters of DIDEOXYNUCLEOSIDES.
Catalyze the hydrolysis of nucleosides with the elimination of ammonia.
A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.
A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.
Guanine is a purine nucleobase, one of the four nucleobases in the nucleic acid of DNA and RNA, involved in forming hydrogen bonds between complementary base pairs in double-stranded DNA molecules.
The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments.
A nucleoside consisting of the base guanine and the sugar deoxyribose.

Yeast asparagine (Asn) tRNA without Q base promotes eukaryotic frameshifting more efficiently than mammalian Asn tRNAs with or without Q base. (1/46)

In this study, we compare the efficiency of Asn tRNA from mammalian sources with and without the highly modified queuosine (Q) base in the wobble position of its anticodon and Asn tRNA from yeast, which naturally lacks Q base, to promote frameshifting. Interestingly, no differences in the ability of the two mammalian Asn tRNAs to promote frameshifting were observed, while yeast tRNA(ASn)(-Q) promoted frameshifting more efficiently than its mammalian counterparts in both rabbit reticulocyte lysates and wheat germ extracts. The shiftability of yeast Asn tRNA is therefore not due, or at least not completely, to the lack of Q base and most likely the shiftiness resides in structural differences elsewhere in the molecule. However, we cannot absolutely rule out a role of Q base in frameshifting as wheat germ extracts and a lysate depleted of most of its tRNA and supplemented with calf liver tRNA contain both Asn tRNA with or without Q base.  (+info)

Increased expression of queuosine synthesizing enzyme, tRNA-guanine transglycosylase, and queuosine levels in tRNA of leukemic cells. (2/46)

Queuosine is a modified nucleoside located at the first position of the tRNA anticodon, which is synthesized by tRNA-guanine transglycosylase (TGT). Although the levels of queuosine in cancer cells have been reported to be lower than those in normal cells, the expression levels of TGT remain to be determined. We determined the expression levels of a subunit of TGT (TGT60KD). Contrary of our expectations, the results revealed higher levels of expression of TGT60KD than that in normal cells, and the level of queuosine in the tRNA fraction corresponded with that of TGT60KD expression. These results suggest the possibilities that the expression levels of TGT60KD regulate TGT activity and the levels of queuosine, and that TGT60KD plays significant roles in carcinogenesis. To our knowledge, this is a first report of increased expression levels of TGT60KD in human cancer cells.  (+info)

An unexpected absence of queuosine modification in the tRNAs of an Escherichia coli B strain. (3/46)

The post-transcriptional processing of tRNAs decorates them with a number of modified bases important for their biological functions. Queuosine, found in the tRNAs with GUN anticodons (Asp, Asn, His, Tyr), is an extensively modified base whose biosynthetic pathway is still unclear. In this study, it was observed that the tRNA(Tyr) from Escherichia coli B105 (a B strain) migrated faster than that from E. coli CA274 (a K-12 strain) on acid urea gels. The organization of tRNA(Tyr) genes in E. coli B105 was found to be typical of the B strains. Subsequent analysis of tRNA(Tyr) and tRNA(His) from several strains of E. coli on acid urea gels, and modified base analysis of tRNA preparations enriched for tRNA(Tyr), showed that E. coli B105 lacked queuosine in its tRNAs. However, the lack of queuosine in tRNAs was not a common feature of all E. coli B strains. The tgt and queA genes in B105 were shown to be functional by their ability to complement tgt and queA mutant strains. These observations suggested a block at the step of the biosynthesis of preQ(1) (or preQ(0)) in the B105 strain. Interestingly, a multicopy vector harbouring a functional tgt gene was toxic to E. coli B105 but not to CA274. Also, in mixed cultures, E. coli B105 was readily competed out by the CA274 strain. The importance of these observations and this novel strain (E. coli B105) in unravelling the mechanism of preQ(1) or preQ(0) biosynthesis is discussed.  (+info)

Identification of four genes necessary for biosynthesis of the modified nucleoside queuosine. (4/46)

Queuosine (Q) is a hypermodified 7-deazaguanosine nucleoside located in the anticodon wobble position of four amino acid-specific tRNAs. In bacteria, Q is produced de novo from GTP via the 7-deazaguanosine precursor preQ1 (7-aminoethyl 7-deazaguanine) by an uncharacterized pathway. PreQ1 is subsequently transferred to its specific tRNA by a tRNA-guanine transglycosylase (TGT) and then further modified in situ to produce Q. Here we use comparative genomics to implicate four gene families (best exemplified by the B. subtilis operon ykvJKLM) as candidates in the preQ1 biosynthetic pathway. Deletions were constructed in genes for each of the four orthologs in Acinetobacter. High pressure liquid chromatography analysis showed the Q nucleoside was absent from the tRNAs of each of four deletion strains. Electrospray ionization mass spectrometry confirmed the absence of Q in each mutant strain. Finally, introduction of the Bacillus subtilis ykvJKLM operon in trans complemented the Q deficiency of the two deletion mutants that were tested. Thus, the products of these four genes (named queC, -D, -E, and -F) are essential for the Q biosynthetic pathway.  (+info)

The promoter of the tgt/sec operon in Escherichia coli is preceded by an upstream activation sequence that contains a high affinity FIS binding site. (5/46)

The tgt/sec operon in E. coli consists of five genes: queA, tgt, ORF12, secD, and secF. QueA and Tgt participate in the biosynthesis of the hypermodified t-RNA nucleoside Queuosine, whereas SecD and SecF are involved in protein secretion. Examination of the promoter region of the operon showed structural similarity to promoter regions of the rrn-operons. An upstream activation sequence (UAS) containing a potential binding site for the factor of inversion stimulation (FIS) was found. Gel retardation assays and DNaseI footprinting indicated, that FIS binds specifically and with high affinity to a site centred at position -58. Binding of FIS caused bending of the DNA, as deduced from circular permutation analysis. Various 5' deletion mutants of the promoter region were constructed and fused to a lacZ reporter gene to determine the influence of the UAS element on the promoter strength. An approximately two-fold activation of the promoter by the UAS element was observed.  (+info)

A truncated aminoacyl-tRNA synthetase modifies RNA. (6/46)

Aminoacyl-tRNA synthetases are modular enzymes composed of a central active site domain to which additional functional domains were appended in the course of evolution. Analysis of bacterial genome sequences revealed the presence of many shorter aminoacyl-tRNA synthetase paralogs. Here we report the characterization of a well conserved glutamyl-tRNA synthetase (GluRS) paralog (YadB in Escherichia coli) that is present in the genomes of >40 species of proteobacteria, cyanobacteria, and actinobacteria. The E. coli yadB gene encodes a truncated GluRS that lacks the C-terminal third of the protein and, consequently, the anticodon binding domain. Generation of a yadB disruption showed the gene to be dispensable for E. coli growth in rich and minimal media. Unlike GluRS, the YadB protein was able to activate glutamate in presence of ATP in a tRNA-independent fashion and to transfer glutamate onto tRNA(Asp). Neither tRNA(Glu) nor tRNA(Gln) were substrates. In contrast to canonical aminoacyl-tRNA, glutamate was not esterified to the 3'-terminal adenosine of tRNA(Asp). Instead, it was attached to the 2-amino-5-(4,5-dihydroxy-2-cyclopenten-1-yl) moiety of queuosine, the modified nucleoside occupying the first anticodon position of tRNA(Asp). Glutamyl-queuosine, like canonical Glu-tRNA, was hydrolyzed by mild alkaline treatment. Analysis of tRNA isolated under acidic conditions showed that this novel modification is present in normal E. coli tRNA; presumably it previously escaped detection as the standard conditions of tRNA isolation include an alkaline deacylation step that also causes hydrolysis of glutamyl-queuosine. Thus, this aminoacyl-tRNA synthetase fragment contributes to standard nucleotide modification of tRNA.  (+info)

A minimalist glutamyl-tRNA synthetase dedicated to aminoacylation of the tRNAAsp QUC anticodon. (7/46)

Escherichia coli encodes YadB, a protein displaying 34% identity with the catalytic core of glutamyl-tRNA synthetase but lacking the anticodon-binding domain. We show that YadB is a tRNA modifying enzyme that evidently glutamylates the queuosine residue, a modified nucleoside at the wobble position of the tRNA(Asp) QUC anticodon. This conclusion is supported by a variety of biochemical data and by the inability of the enzyme to glutamylate tRNA(Asp) isolated from an E.coli tRNA-guanosine transglycosylase minus strain deprived of the capacity to exchange guanosine 34 with queuosine. Structural mimicry between the tRNA(Asp) anticodon stem and the tRNA(Glu) amino acid acceptor stem in prokaryotes encoding YadB proteins indicates that the function of these tRNA modifying enzymes, which we rename glutamyl-Q tRNA(Asp) synthetases, is conserved among prokaryotes.  (+info)

From cyclohydrolase to oxidoreductase: discovery of nitrile reductase activity in a common fold. (8/46)

The enzyme YkvM from Bacillus subtilis was identified previously along with three other enzymes (YkvJKL) in a bioinformatics search for enzymes involved in the biosynthesis of queuosine, a 7-deazaguanine modified nucleoside found in tRNA(GUN) of Bacteria and Eukarya. Genetic analysis of ykvJKLM mutants in Acinetobacter confirmed that each was essential for queuosine biosynthesis, and the genes were renamed queCDEF. QueF exhibits significant homology to the type I GTP cyclohydrolases characterized by FolE. Given that GTP is the precursor to queuosine and that a cyclohydrolase-like reaction was postulated as the initial step in queuosine biosynthesis, QueF was proposed to be the putative cyclohydrolase-like enzyme responsible for this reaction. We have cloned the queF genes from B. subtilis and Escherichia coli and characterized the recombinant enzymes. Contrary to the predictions based on sequence analysis, we discovered that the enzymes, in fact, catalyze a mechanistically unrelated reaction, the NADPH-dependent reduction of 7-cyano-7-deazaguanineto7-aminomethyl-7-deazaguanine, a late step in the biosynthesis of queuosine. We report here in vitro and in vivo studies that demonstrate this catalytic activity, as well as preliminary biochemical and bioinformatics analysis that provide insight into the structure of this family of enzymes.  (+info)

Guanosine is a nucleoside that consists of a guanine base linked to a ribose sugar molecule through a beta-N9-glycosidic bond. It plays a crucial role in various biological processes, such as serving as a building block for DNA and RNA during replication and transcription. Guanosine triphosphate (GTP) and guanosine diphosphate (GDP) are important energy carriers and signaling molecules involved in intracellular regulation. Additionally, guanosine has been studied for its potential role as a neuroprotective agent and possible contribution to cell-to-cell communication.

I'm sorry for any confusion, but "Nucleoside Q" is not a recognized or established term in medical or biological nomenclature. Nucleosides are organic molecules consisting of a pentose sugar (ribose or deoxyribose) linked to a nitrogenous base (adenine, guanine, cytosine, thymine, or uracil). There is no "Q" nucleoside in the standard nomenclature.

If you have any questions about specific nucleosides or related compounds, I'd be happy to try and help clarify those for you!

Transfer RNA (tRNA) is a type of RNA molecule that plays a crucial role in protein synthesis, the process by which cells create proteins. In protein synthesis, tRNAs serve as adaptors, translating the genetic code present in messenger RNA (mRNA) into the corresponding amino acids required to build a protein.

Each tRNA molecule has a distinct structure, consisting of approximately 70-90 nucleotides arranged in a cloverleaf shape with several loops and stems. The most important feature of a tRNA is its anticodon, a sequence of three nucleotides located in one of the loops. This anticodon base-pairs with a complementary codon on the mRNA during translation, ensuring that the correct amino acid is added to the growing polypeptide chain.

Before tRNAs can participate in protein synthesis, they must be charged with their specific amino acids through an enzymatic process involving aminoacyl-tRNA synthetases. These enzymes recognize and bind to both the tRNA and its corresponding amino acid, forming a covalent bond between them. Once charged, the aminoacyl-tRNA complex is ready to engage in translation and contribute to protein formation.

In summary, transfer RNA (tRNA) is a small RNA molecule that facilitates protein synthesis by translating genetic information from messenger RNA into specific amino acids, ultimately leading to the creation of functional proteins within cells.

A nucleoside is a biochemical molecule that consists of a pentose sugar (a type of simple sugar with five carbon atoms) covalently linked to a nitrogenous base. The nitrogenous base can be one of several types, including adenine, guanine, cytosine, thymine, or uracil. Nucleosides are important components of nucleic acids, such as DNA and RNA, which are the genetic materials found in cells. They play a crucial role in various biological processes, including cell division, protein synthesis, and gene expression.

Purine nucleosides are fundamental components of nucleic acids, which are the genetic materials found in all living organisms. A purine nucleoside is composed of a purine base (either adenine or guanine) linked to a sugar molecule, specifically ribose in the case of purine nucleosides.

The purine base and sugar moiety are joined together through a glycosidic bond at the 1' position of the sugar. These nucleosides play crucial roles in various biological processes, including energy transfer, signal transduction, and as precursors for the biosynthesis of DNA and RNA.

In the human body, purine nucleosides can be derived from the breakdown of endogenous nucleic acids or through the dietary intake of nucleoproteins. They are further metabolized to form uric acid, which is eventually excreted in the urine. Elevated levels of uric acid in the body can lead to the formation of uric acid crystals and contribute to the development of gout or kidney stones.

Pyrimidine nucleosides are organic compounds that consist of a pyrimidine base (a heterocyclic aromatic ring containing two nitrogen atoms and four carbon atoms) linked to a sugar molecule, specifically ribose or deoxyribose, via a β-glycosidic bond. The pyrimidine bases found in nucleosides can be cytosine (C), thymine (T), or uracil (U). When the sugar component is ribose, it is called a pyrimidine nucleoside, and when it is linked to deoxyribose, it is referred to as a deoxy-pyrimidine nucleoside. These molecules play crucial roles in various biological processes, particularly in the structure and function of nucleic acids such as DNA and RNA.

Nucleoside transport proteins (NTTs) are membrane-bound proteins responsible for the facilitated diffusion of nucleosides and related deoxynucleosides across the cell membrane. These proteins play a crucial role in the uptake of nucleosides, which serve as precursors for DNA and RNA synthesis, as well as for the salvage of nucleotides in the cell.

There are two main types of NTTs: concentrative (or sodium-dependent) nucleoside transporters (CNTs) and equilibrative (or sodium-independent) nucleoside transporters (ENTs). CNTs mainly facilitate the uptake of nucleosides against a concentration gradient, using the energy derived from the sodium ion gradient. In contrast, ENTs mediate bidirectional transport, allowing for the equalization of intracellular and extracellular nucleoside concentrations.

Nucleoside transport proteins have been identified in various organisms, including humans, and are involved in numerous physiological processes, such as cell proliferation, differentiation, and survival. Dysregulation of NTTs has been implicated in several pathological conditions, including cancer and viral infections, making them potential targets for therapeutic intervention.

Equilibrative Nucleoside Transporter 1 (ENT1), also known as SLC29A1, is a protein that functions as a membrane transport protein. It is responsible for the facilitated diffusion of nucleosides and some related drugs across the cell membrane. The term "equilibrative" refers to the fact that this transporter moves substrates down their concentration gradient, meaning it facilitates the movement of molecules from an area of high concentration to an area of low concentration. ENT1 is widely expressed in various tissues, including the liver, kidney, intestine, and brain, playing a crucial role in nucleoside homeostasis and the cellular uptake of nucleoside-analog drugs used in cancer chemotherapy.

Thioinosine is not a medical term itself, but it is a chemical compound that has been studied in the field of medical research. Thioinosine is an analogue of the nucleoside inosine, where the oxygen atom in the heterocyclic ring is replaced by a sulfur atom.

In the context of medical research, thioinosine has been investigated for its potential immunomodulatory and antiviral properties. It has been studied as an inhibitor of certain enzymes involved in the replication of viruses, such as HIV and hepatitis C virus. However, it is not currently approved for use as a medication in clinical practice.

Purine-nucleoside phosphorylase (PNP) is an enzyme that plays a crucial role in the metabolism of purines, which are essential components of nucleic acids (DNA and RNA). The medical definition of 'Purine-Nucleoside Phosphorylase' refers to the physiological function of this enzyme in the human body.

PNP is responsible for catalyzing the phosphorolytic cleavage of purine nucleosides, such as inosine and guanosine, into their respective purine bases (hypoxanthine and guanine) and ribose-1-phosphate. This reaction is essential for the recycling and salvage of purine bases, allowing the body to conserve energy and resources needed for de novo purine biosynthesis.

In a clinical or medical context, deficiencies in PNP activity can lead to serious consequences, particularly affecting the immune system and the nervous system. A genetic disorder called Purine-Nucleoside Phosphorylase Deficiency (PNP Deficiency) is characterized by significantly reduced or absent PNP enzyme activity, leading to an accumulation of toxic purine nucleosides and deoxypurine nucleosides. This accumulation can cause severe combined immunodeficiency (SCID), neurological impairments, and other complications, making it a critical area of study in medical research.

Nucleoside-diphosphate kinase (NDK) is an enzyme that plays a crucial role in the regulation of intracellular levels of nucleoside triphosphates and diphosphates. These nucleotides are essential for various cellular processes, including DNA replication, transcription, translation, and energy metabolism.

NDK catalyzes the transfer of a phosphate group from a nucleoside triphosphate (most commonly ATP or GTP) to a nucleoside diphosphate (NDP), converting it into a nucleoside triphosphate (NTP). The reaction can be summarized as follows:

NTP + NDP ↔ NDP + NTP

The enzyme has several isoforms, which are differentially expressed in various tissues and cellular compartments. In humans, there are nine known isoforms of NDK, classified into three subfamilies: NM23-H (NME1), NM23-H2 (NME2), and NME4-8. These isoforms share a conserved catalytic core but differ in their regulatory domains and cellular localization.

NDK has been implicated in several physiological processes, such as cell proliferation, differentiation, and survival. Dysregulation of NDK activity has been associated with various pathological conditions, including cancer, neurodegenerative diseases, and viral infections.

Inosine is not a medical condition but a naturally occurring compound called a nucleoside, which is formed from the combination of hypoxanthine and ribose. It is an intermediate in the metabolic pathways of purine nucleotides, which are essential components of DNA and RNA. Inosine has been studied for its potential therapeutic benefits in various medical conditions, including neurodegenerative disorders, cardiovascular diseases, and cancer. However, more research is needed to fully understand its mechanisms and clinical applications.

Uridine is a nucleoside that consists of a pyrimidine base (uracil) linked to a pentose sugar (ribose). It is a component of RNA, where it pairs with adenine. Uridine can also be found in various foods such as beer, broccoli, yeast, and meat. In the body, uridine can be synthesized from orotate or from the breakdown of RNA. It has several functions, including acting as a building block for RNA, contributing to energy metabolism, and regulating cell growth and differentiation. Uridine is also available as a dietary supplement and has been studied for its potential benefits in various health conditions.

Equilibrative Nucleoside Transporter 2 (ENT2) is a type of protein found in the cell membrane that facilitates the bidirectional transport of nucleosides, which are the building blocks of DNA and RNA, between the intracellular and extracellular spaces. ENT2 is a member of the solute carrier 29 (SLC29) family of transporters and is widely expressed in various tissues, including the brain, liver, kidney, and intestine.

ENT2 plays an essential role in maintaining nucleoside homeostasis by regulating their uptake and efflux across the cell membrane. It has a high affinity for purine nucleosides such as adenosine and guanosine, and to a lesser extent, pyrimidine nucleosides such as uridine and thymidine. The activity of ENT2 is critical in regulating extracellular adenosine levels, which have important implications for various physiological processes, including neurotransmission, inflammation, and cancer.

In addition to its role in nucleoside transport, ENT2 has been implicated in the development of drug resistance in cancer cells. Certain chemotherapeutic agents, such as nucleoside analogs, utilize ENT2 for their uptake into cells. However, overexpression of ENT2 in cancer cells can lead to increased efflux of these drugs, resulting in reduced intracellular concentrations and decreased therapeutic effectiveness. Therefore, ENT2 is an attractive target for the development of novel strategies to overcome drug resistance in cancer therapy.

Nucleoside-triphosphatase (NTPase) is not a medical term per se, but rather a biochemical term. However, it is often used in the context of molecular biology and genetics, which are essential components of medical research and practice. Therefore, I will provide a definition related to these fields.

Nucleoside-triphosphatase (NTPase) refers to an enzyme that catalyzes the hydrolysis of nucleoside triphosphates (NTPs) into nucleoside diphosphates (NDPs) and inorganic phosphate (Pi). NTPs, such as adenosine triphosphate (ATP), guanosine triphosphate (GTP), cytidine triphosphate (CTP), and uridine triphosphate (UTP), are crucial for energy transfer in cells.

In the context of molecular biology, NTPases play essential roles in various cellular processes, including DNA replication, transcription, translation, and degradation. For example, DNA polymerase, an enzyme involved in DNA replication, is a type of NTPase that utilizes dNTPs (deoxynucleoside triphosphates) to synthesize new DNA strands. Similarly, RNA polymerase, which catalyzes the transcription of DNA into RNA, uses NTPs as substrates and has NTPase activity.

In summary, Nucleoside-triphosphatase (NTPase) is an enzyme that hydrolyzes nucleoside triphosphates (NTPs), releasing energy and playing a critical role in various cellular processes, including DNA replication, transcription, translation, and degradation.

Cytidine is a nucleoside, which consists of the sugar ribose and the nitrogenous base cytosine. It is an important component of RNA (ribonucleic acid), where it pairs with guanosine via hydrogen bonding to form a base pair. Cytidine can also be found in some DNA (deoxyribonucleic acid) sequences, particularly in viral DNA and in mitochondrial DNA.

Cytidine can be phosphorylated to form cytidine monophosphate (CMP), which is a nucleotide that plays a role in various biochemical reactions in the body. CMP can be further phosphorylated to form cytidine diphosphate (CDP) and cytidine triphosphate (CTP), which are involved in the synthesis of lipids, glycogen, and other molecules.

Cytidine is also available as a dietary supplement and has been studied for its potential benefits in treating various health conditions, such as liver disease and cancer. However, more research is needed to confirm these potential benefits and establish safe and effective dosages.

Ribonucleosides are organic compounds that consist of a nucleoside bound to a ribose sugar. Nucleosides are formed when a nitrogenous base (such as adenine, guanine, uracil, cytosine, or thymine) is attached to a sugar molecule (either ribose or deoxyribose) via a beta-glycosidic bond. In the case of ribonucleosides, the sugar component is D-ribose. Ribonucleosides play important roles in various biological processes, particularly in the storage, transfer, and expression of genetic information within cells. When ribonucleosides are phosphorylated, they become the building blocks of RNA (ribonucleic acid), a crucial biomolecule involved in protein synthesis and other cellular functions. Examples of ribonucleosides include adenosine, guanosine, uridine, cytidine, and inosine.

Nucleotides are the basic structural units of nucleic acids, such as DNA and RNA. They consist of a nitrogenous base (adenine, guanine, cytosine, thymine or uracil), a pentose sugar (ribose in RNA and deoxyribose in DNA) and one to three phosphate groups. Nucleotides are linked together by phosphodiester bonds between the sugar of one nucleotide and the phosphate group of another, forming long chains known as polynucleotides. The sequence of these nucleotides determines the genetic information carried in DNA and RNA, which is essential for the functioning, reproduction and survival of all living organisms.

Adenosine is a purine nucleoside that is composed of a sugar (ribose) and the base adenine. It plays several important roles in the body, including serving as a precursor for the synthesis of other molecules such as ATP, NAD+, and RNA.

In the medical context, adenosine is perhaps best known for its use as a pharmaceutical agent to treat certain cardiac arrhythmias. When administered intravenously, it can help restore normal sinus rhythm in patients with paroxysmal supraventricular tachycardia (PSVT) by slowing conduction through the atrioventricular node and interrupting the reentry circuit responsible for the arrhythmia.

Adenosine can also be used as a diagnostic tool to help differentiate between narrow-complex tachycardias of supraventricular origin and those that originate from below the ventricles (such as ventricular tachycardia). This is because adenosine will typically terminate PSVT but not affect the rhythm of VT.

It's worth noting that adenosine has a very short half-life, lasting only a few seconds in the bloodstream. This means that its effects are rapidly reversible and generally well-tolerated, although some patients may experience transient symptoms such as flushing, chest pain, or shortness of breath.

Formycins are a group of antibiotics that are derived from certain strains of Streptomyces bacteria. They include formycin B (also known as pyrazofurin), which is an antiviral and antimetabolite drug that works by interfering with the production of genetic material in cells. Formycins are not widely used in clinical medicine due to their potential toxicity and the availability of other effective antibiotics and antiviral drugs.

Pentosyltransferases are a group of enzymes that catalyze the transfer of a pentose (a sugar containing five carbon atoms) molecule from one compound to another. These enzymes play important roles in various biochemical pathways, including the biosynthesis of nucleotides, glycoproteins, and other complex carbohydrates.

One example of a pentosyltransferase is the enzyme that catalyzes the addition of a ribose sugar to form a glycosidic bond with a purine or pyrimidine base during the biosynthesis of nucleotides, which are the building blocks of DNA and RNA.

Another example is the enzyme that adds xylose residues to proteins during the formation of glycoproteins, which are proteins that contain covalently attached carbohydrate chains. These enzymes are essential for many biological processes and have been implicated in various diseases, including cancer and neurodegenerative disorders.

NM23 nucleoside diphosphate kinases are a group of proteins that play a role in regulating cellular functions, including signal transduction, cell proliferation, and differentiation. They are named after the NM23 gene that encodes them, which was initially identified as a potential metastasis suppressor.

NM23 nucleoside diphosphate kinases have the ability to transfer phosphate groups between nucleoside diphosphates (NDPs) and nucleoside triphosphates (NTPs), thereby maintaining the balance of these molecules in cells. This enzymatic activity is important for various cellular processes, such as DNA replication, repair, and transcription.

There are several isoforms of NM23 nucleoside diphosphate kinases, including NM23-H1, NM23-H2, and NM23-H4, which differ in their tissue distribution and functions. While the role of NM23 as a metastasis suppressor has been debated, recent studies suggest that it may be involved in regulating cell motility and invasion through its effects on actin dynamics and microtubule organization.

Overall, NM23 nucleoside diphosphate kinases are important regulators of cellular homeostasis and have been implicated in various physiological and pathological processes, including cancer metastasis, inflammation, and neurodegenerative diseases.

Reverse Transcriptase Inhibitors (RTIs) are a class of antiretroviral drugs that are primarily used in the treatment and management of HIV (Human Immunodeficiency Virus) infection. They work by inhibiting the reverse transcriptase enzyme, which is essential for the replication of HIV.

HIV is a retrovirus, meaning it has an RNA genome and uses a unique enzyme called reverse transcriptase to convert its RNA into DNA. This process is necessary for the virus to integrate into the host cell's genome and replicate. Reverse Transcriptase Inhibitors interfere with this process by binding to the reverse transcriptase enzyme, preventing it from converting the viral RNA into DNA.

RTIs can be further divided into two categories: nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). NRTIs are analogs of the building blocks of DNA, which get incorporated into the growing DNA chain during replication, causing termination of the chain. NNRTIs bind directly to the reverse transcriptase enzyme, causing a conformational change that prevents it from functioning.

By inhibiting the reverse transcriptase enzyme, RTIs can prevent the virus from replicating and reduce the viral load in an infected individual, thereby slowing down the progression of HIV infection and AIDS (Acquired Immunodeficiency Syndrome).

Equilibrative nucleoside transport proteins (ENTs) are a type of membrane transporter that regulate the bidirectional movement of nucleosides across the cell membrane. They facilitate the diffusion of nucleosides down their concentration gradient, hence the term "equilibrative." These transport proteins play a crucial role in maintaining intracellular nucleoside concentrations and ensuring proper nucleotide synthesis for various cellular processes, including DNA replication, repair, and gene expression. There are two major families of ENTs: the human equilibrative nucleoside transporters (hENTs) and the concentrative nucleoside transporters (CNTs). The hENT family includes four members (hENT1-4), while the CNT family consists of three members (CNT1-3). These transport proteins have been identified as potential targets for cancer therapy, as inhibiting their function can selectively sensitize tumor cells to nucleoside analog-based chemotherapies.

Deoxyribonucleosides are chemical compounds that constitute the basic building blocks of DNA, one of the two nucleic acids found in cells. They consist of a sugar molecule called deoxyribose, a nitrogenous base (either adenine, guanine, cytosine, or thymine), and a phosphate group.

The nitrogenous base is attached to the 1' carbon atom of the deoxyribose sugar, forming a glycosidic bond. The phosphate group is linked to the 5' carbon atom of the deoxyribose sugar through an ester linkage, creating a phosphodiester bond with another deoxyribonucleoside.

When multiple deoxyribonucleosides are joined together through their phosphate groups, they form a polynucleotide chain, which is the backbone of DNA. The sequence of nitrogenous bases along this chain encodes genetic information that determines the characteristics and functions of living organisms.

Deoxyribonucleosides play a crucial role in various biological processes, including DNA replication, repair, and transcription. They are also used as therapeutic agents for the treatment of certain genetic disorders and cancer.

Deoxyadenosine is a chemical compound that is a component of DNA, one of the nucleic acids that make up the genetic material of living organisms. Specifically, deoxyadenosine is a nucleoside, which is a molecule consisting of a sugar (in this case, deoxyribose) bonded to a nitrogenous base (in this case, adenine).

Deoxyribonucleosides like deoxyadenosine are the building blocks of DNA, along with phosphate groups. In DNA, deoxyadenosine pairs with thymidine via hydrogen bonds to form one of the four rungs in the twisted ladder structure of the double helix.

It is important to note that there is a similar compound called adenosine, which contains an extra oxygen atom on the sugar molecule (making it a ribonucleoside) and is a component of RNA, another nucleic acid involved in protein synthesis and other cellular processes.

Complement C1q is a protein that is part of the complement system, which is a group of proteins in the blood that help to eliminate pathogens and damaged cells from the body. C1q is the first component of the classical complement pathway, which is activated by the binding of C1q to antibodies that are attached to the surface of a pathogen or damaged cell.

C1q is composed of six identical polypeptide chains, each containing a collagen-like region and a globular head region. The globular heads can bind to various structures, including the Fc regions of certain antibodies, immune complexes, and some types of cells. When C1q binds to an activating surface, it triggers a series of proteolytic reactions that lead to the activation of other complement components and the formation of the membrane attack complex (MAC), which can punch holes in the membranes of pathogens or damaged cells, leading to their destruction.

In addition to its role in the immune system, C1q has also been found to have roles in various physiological processes, including tissue remodeling, angiogenesis, and the clearance of apoptotic cells. Dysregulation of the complement system, including abnormalities in C1q function, has been implicated in a variety of diseases, including autoimmune disorders, inflammatory diseases, and neurodegenerative conditions.

Adenine is a purine nucleotide base that is a fundamental component of DNA and RNA, the genetic material of living organisms. In DNA, adenine pairs with thymine via double hydrogen bonds, while in RNA, it pairs with uracil. Adenine is essential for the structure and function of nucleic acids, as well as for energy transfer reactions in cells through its role in the formation of adenosine triphosphate (ATP), the primary energy currency of the cell.

Dilazep is a medication that belongs to a class of drugs called calcium channel blockers. It is primarily used in the management of angina pectoris, which is chest pain caused by reduced blood flow to the heart muscle. Dilazep works by relaxing and widening the blood vessels that supply the heart, thereby improving blood flow and reducing the workload on the heart.

The chemical name for Dilazep is (E)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid diamide. It is not commonly used in many countries, and other calcium channel blockers such as verapamil, nifedipine, and amlodipine are more frequently prescribed for the treatment of angina pectoris.

It's important to note that like all medications, Dilazep can have side effects, including headache, dizziness, and swelling in the extremities. It should be used under the close supervision of a healthcare provider, who can monitor its effectiveness and potential side effects.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Dideoxynucleosides are a type of modified nucleoside used in the treatment of certain viral infections, such as HIV and HBV. These compounds lack a hydroxyl group (-OH) at the 3'-carbon position of the sugar moiety, which prevents them from being further metabolized into DNA.

When incorporated into a growing DNA chain during reverse transcription, dideoxynucleosides act as chain terminators, inhibiting viral replication. Common examples of dideoxynucleosides include zidovudine (AZT), didanosine (ddI), stavudine (d4T), and lamivudine (3TC). These drugs are often used in combination with other antiretroviral agents to form highly active antiretroviral therapy (HAART) regimens for the treatment of HIV infection.

Tubercidin is not a medical term itself, but it is a type of antibiotic that belongs to the class of compounds known as nucleoside antibiotics. Specifically, tubercidin is a naturally occurring adenine analogue that is produced by several species of Streptomyces bacteria.

Tubercidin has been found to have antimicrobial and antitumor activities. It works by inhibiting the enzyme adenosine deaminase, which plays a crucial role in the metabolism of nucleotides in cells. By inhibiting this enzyme, tubercidin can interfere with DNA and RNA synthesis, leading to cell death.

While tubercidin has shown promise as an anticancer agent in preclinical studies, its clinical use is limited due to its toxicity and potential for causing mutations in normal cells. Therefore, it is primarily used for research purposes to study the mechanisms of nucleotide metabolism and the effects of nucleoside analogues on cell growth and differentiation.

Zidovudine is defined as an antiretroviral medication used to prevent and treat HIV/AIDS. It is a reverse transcriptase inhibitor (NRTI) that works by blocking the action of the reverse transcriptase enzyme, thereby preventing the virus from replicating in human cells.

Zidovudine is often used in combination with other antiretroviral drugs as part of highly active antiretroviral therapy (HAART) to manage HIV infection and reduce the risk of transmission. It is also used to prevent mother-to-child transmission of HIV during pregnancy, labor, delivery, and breastfeeding.

The most common side effects of zidovudine include headache, nausea, vomiting, and muscle pain. Prolonged use of zidovudine can lead to serious side effects such as anemia, neutropenia, and lactic acidosis. Therefore, regular monitoring of blood counts and liver function tests is necessary during treatment with this medication.

Antiviral agents are a class of medications that are designed to treat infections caused by viruses. Unlike antibiotics, which target bacteria, antiviral agents interfere with the replication and infection mechanisms of viruses, either by inhibiting their ability to replicate or by modulating the host's immune response to the virus.

Antiviral agents are used to treat a variety of viral infections, including influenza, herpes simplex virus (HSV) infections, human immunodeficiency virus (HIV) infection, hepatitis B and C, and respiratory syncytial virus (RSV) infections.

These medications can be administered orally, intravenously, or topically, depending on the type of viral infection being treated. Some antiviral agents are also used for prophylaxis, or prevention, of certain viral infections.

It is important to note that antiviral agents are not effective against all types of viruses and may have significant side effects. Therefore, it is essential to consult with a healthcare professional before starting any antiviral therapy.

Arabinonucleosides are glycosylamines derived from arabinose, a monosaccharide (simple sugar) that is a component of certain complex carbohydrates. In an arabinonucleoside, the arabinose molecule is linked to a nitrogenous base, such as adenine, guanine, cytosine, uracil, or thymine, through a glycosidic bond. These types of compounds are not typically found in nature but can be synthesized in the laboratory for research purposes. They may have potential applications in the development of new drugs, particularly in the area of antiviral and anticancer therapy.

Purines are heterocyclic aromatic organic compounds that consist of a pyrimidine ring fused to an imidazole ring. They are fundamental components of nucleotides, which are the building blocks of DNA and RNA. In the body, purines can be synthesized endogenously or obtained through dietary sources such as meat, seafood, and certain vegetables.

Once purines are metabolized, they are broken down into uric acid, which is excreted by the kidneys. Elevated levels of uric acid in the body can lead to the formation of uric acid crystals, resulting in conditions such as gout or kidney stones. Therefore, maintaining a balanced intake of purine-rich foods and ensuring proper kidney function are essential for overall health.

Deoxycytidine kinase (dCK) is an enzyme that plays a crucial role in the phosphorylation of deoxycytidine and its analogs, which are important components in the intracellular metabolism of DNA precursors. The enzyme catalyzes the transfer of a phosphate group from adenosine triphosphate (ATP) to the hydroxyl group at the 5' carbon atom of deoxycytidine, forming deoxycytidine monophosphate (dCMP).

Deoxycytidine kinase is a key enzyme in the salvage pathway of pyrimidine nucleotide synthesis and is also involved in the activation of many antiviral and anticancer drugs that are analogs of deoxycytidine. The activity of dCK is tightly regulated, and its expression levels can vary depending on the cell type and physiological conditions.

In addition to its role in nucleotide metabolism, dCK has been implicated in various biological processes, including DNA damage response, cell cycle regulation, and apoptosis. Abnormalities in dCK activity or expression have been associated with several human diseases, including cancer and viral infections. Therefore, modulation of dCK activity has emerged as a potential therapeutic strategy for the treatment of these conditions.

Organophosphonates are a class of organic compounds characterized by the presence of a carbon-phosphorus bond. They contain a phosphonic acid group, which consists of a phosphorus atom bonded to four oxygen or nitrogen atoms, with one of those bonds being replaced by a carbon atom.

In a medical context, organophosphonates are commonly used as radiopharmaceuticals in diagnostic nuclear medicine procedures, such as bone scans. These compounds have the ability to bind to hydroxyapatite, the mineral component of bones, and can be labeled with radioactive isotopes for imaging purposes. They may also be used in therapeutic settings, including as treatments for conditions such as tumor-induced hypercalcemia and Paget's disease of bone.

It is important to note that organophosphonates are distinct from organophosphates, another class of compounds that contain a phosphorus atom bonded to three oxygen or sulfur atoms and one carbon atom. Organophosphates have been widely used as pesticides and chemical warfare agents, and can pose significant health risks due to their toxicity.

Pyrimidine phosphorylases are a group of enzymes that play a crucial role in the metabolism of pyrimidines, which are nitrogenous bases found in nucleic acids such as DNA and RNA. These enzymes catalyze the reversible phosphorolytic cleavage of pyrimidine nucleosides into ribose-1-phosphate and a free base.

There are two main types of pyrimidine phosphorylases: cytosine phosphorylase (CP) and thymidine phosphorylase (TP). CP catalyzes the conversion of cytosine to uracil, while TP converts thymidine to thymine. These enzymes are important in maintaining the balance of pyrimidines in cells and are also involved in the salvage pathway for nucleotide synthesis.

Deficiencies or mutations in these enzymes can lead to various genetic disorders, including neurological and developmental abnormalities. Additionally, TP has been studied as a potential target for cancer therapy due to its role in angiogenesis and tumor growth.

Thymidine is a pyrimidine nucleoside that consists of a thymine base linked to a deoxyribose sugar by a β-N1-glycosidic bond. It plays a crucial role in DNA replication and repair processes as one of the four nucleosides in DNA, along with adenosine, guanosine, and cytidine. Thymidine is also used in research and clinical settings for various purposes, such as studying DNA synthesis or as a component of antiviral and anticancer therapies.

Thionucleosides are a type of modified nucleoside where the oxygen atom in the sugar component (ribose or deoxyribose) is replaced by a sulfur atom. This modification can occur naturally or be introduced synthetically. The resulting compounds have been studied for their potential biological activity, including antiviral and anticancer properties. However, they are not typically used as a standard medical treatment at this time.

Ribonucleotides are organic compounds that consist of a ribose sugar, a phosphate group, and a nitrogenous base. They are the building blocks of RNA (ribonucleic acid), one of the essential molecules in all living organisms. The nitrogenous bases found in ribonucleotides include adenine, uracil, guanine, and cytosine. These molecules play crucial roles in various biological processes, such as protein synthesis, gene expression, and cellular energy production. Ribonucleotides can also be involved in cell signaling pathways and serve as important cofactors for enzymatic reactions.

Zalcitabine (also known as ddC) is an antiretroviral medication used in the treatment of HIV infection. It belongs to a class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs). Zalcitabine works by interfering with the replication of the virus, thus slowing down the progression of the disease.

The medical definition of Zalcitabine is: "A synthetic pyrimidine nucleoside analogue used as an antiretroviral agent in the treatment of HIV infection. It is converted to its active 5'-triphosphate form, which inhibits the activity of reverse transcriptase and results in chain termination."

It is important to note that Zalcitabine has been largely replaced by other antiretroviral drugs due to its significant side effects and the development of better treatment options.

Deoxyuridine is a chemical compound that is a component of DNA. It is a nucleoside, which means it consists of a sugar (deoxyribose) linked to a nitrogenous base (uracil). In the case of deoxyuridine, the uracil is not methylated, which differentiates it from thymidine.

Deoxyuridine can be converted into deoxyuridine monophosphate (dUMP) by the enzyme thymidine kinase. The dUMP can then be converted into deoxythymidine triphosphate (dTTP), which is a building block of DNA, through a series of reactions involving other enzymes.

Deoxyuridine has been used in research and medicine as a marker for DNA synthesis and repair. It can also be used to inhibit the growth of certain types of cells, such as cancer cells, by disrupting their DNA synthesis.

Uridine phosphorylase is an enzyme that plays a role in the metabolism of nucleosides, specifically uridine. The medical definition of 'uridine phosphorylase' is:

An enzyme (EC 2.4.2.3) involved in the reversible phosphorolysis of uridine to uracil and ribose-1-phosphate. This enzyme also catalyzes the phosphorolytic cleavage of other pyrimidine nucleosides, such as cytidine and thymidine, into their respective bases and ribose-1-phosphate. Uridine phosphorylase has a role in the salvage pathway of pyrimidine nucleotide biosynthesis and is found in various tissues, including the liver, intestines, and blood cells. Deficiency or dysfunction of uridine phosphorylase can lead to impaired nucleotide metabolism and may be associated with certain medical conditions, such as hereditary orotic aciduria.

Anti-HIV agents are a class of medications specifically designed to treat HIV (Human Immunodeficiency Virus) infection. These drugs work by interfering with various stages of the HIV replication cycle, preventing the virus from infecting and killing CD4+ T cells, which are crucial for maintaining a healthy immune system.

There are several classes of anti-HIV agents, including:

1. Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs): These drugs act as faulty building blocks that the virus incorporates into its genetic material, causing the replication process to halt. Examples include zidovudine (AZT), lamivudine (3TC), and tenofovir.
2. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs): These medications bind directly to the reverse transcriptase enzyme, altering its shape and preventing it from functioning properly. Examples include efavirenz, nevirapine, and rilpivirine.
3. Protease Inhibitors (PIs): These drugs target the protease enzyme, which is responsible for cleaving viral polyproteins into functional components. By inhibiting this enzyme, PIs prevent the formation of mature, infectious virus particles. Examples include atazanavir, darunavir, and lopinavir.
4. Integrase Strand Transfer Inhibitors (INSTIs): These medications block the integrase enzyme, which is responsible for inserting the viral genetic material into the host cell's DNA. By inhibiting this step, INSTIs prevent the virus from establishing a permanent infection within the host cell. Examples include raltegravir, dolutegravir, and bictegravir.
5. Fusion/Entry Inhibitors: These drugs target different steps of the viral entry process, preventing HIV from infecting CD4+ T cells. Examples include enfuvirtide (T-20), maraviroc, and ibalizumab.
6. Post-Attachment Inhibitors: This class of medications prevents the virus from attaching to the host cell's receptors, thereby inhibiting infection. Currently, there is only one approved post-attachment inhibitor, fostemsavir.

Combination therapy using multiple classes of antiretroviral drugs has been shown to effectively suppress viral replication and improve clinical outcomes in people living with HIV. Regular adherence to the prescribed treatment regimen is crucial for maintaining an undetectable viral load and reducing the risk of transmission.

Dipyridamole is a medication that belongs to a class of drugs called antiplatelet agents. It works by preventing platelets in your blood from sticking together to form clots. Dipyridamole is often used in combination with aspirin to prevent stroke and other complications in people who have had a heart valve replacement or a type of irregular heartbeat called atrial fibrillation.

Dipyridamole can also be used as a stress agent in myocardial perfusion imaging studies, which are tests used to evaluate blood flow to the heart. When used for this purpose, dipyridamole is given intravenously and works by dilating the blood vessels in the heart, allowing more blood to flow through them and making it easier to detect areas of reduced blood flow.

The most common side effects of dipyridamole include headache, dizziness, and gastrointestinal symptoms such as diarrhea, nausea, and vomiting. In rare cases, dipyridamole can cause more serious side effects, such as allergic reactions, abnormal heart rhythms, or low blood pressure. It is important to take dipyridamole exactly as directed by your healthcare provider and to report any unusual symptoms or side effects promptly.

HIV Reverse Transcriptase is an enzyme that is encoded by the HIV-1 and HIV-2 viruses. It plays a crucial role in the replication cycle of the human immunodeficiency virus (HIV), which causes AIDS.

Reverse transcriptase is responsible for transcribing the viral RNA genome into DNA, a process known as reverse transcription. This allows the viral genetic material to integrate into the host cell's DNA and replicate along with it, leading to the production of new virus particles.

The enzyme has three distinct activities: a polymerase activity that synthesizes DNA using RNA as a template, an RNase H activity that degrades the RNA template during reverse transcription, and a DNA-dependent DNA polymerase activity that synthesizes DNA using a DNA template.

Reverse transcriptase inhibitors are a class of antiretroviral drugs used to treat HIV infection. They work by binding to and inhibiting the activity of the reverse transcriptase enzyme, thereby preventing the virus from replicating.

Substrate specificity in the context of medical biochemistry and enzymology refers to the ability of an enzyme to selectively bind and catalyze a chemical reaction with a particular substrate (or a group of similar substrates) while discriminating against other molecules that are not substrates. This specificity arises from the three-dimensional structure of the enzyme, which has evolved to match the shape, charge distribution, and functional groups of its physiological substrate(s).

Substrate specificity is a fundamental property of enzymes that enables them to carry out highly selective chemical transformations in the complex cellular environment. The active site of an enzyme, where the catalysis takes place, has a unique conformation that complements the shape and charge distribution of its substrate(s). This ensures efficient recognition, binding, and conversion of the substrate into the desired product while minimizing unwanted side reactions with other molecules.

Substrate specificity can be categorized as:

1. Absolute specificity: An enzyme that can only act on a single substrate or a very narrow group of structurally related substrates, showing no activity towards any other molecule.
2. Group specificity: An enzyme that prefers to act on a particular functional group or class of compounds but can still accommodate minor structural variations within the substrate.
3. Broad or promiscuous specificity: An enzyme that can act on a wide range of structurally diverse substrates, albeit with varying catalytic efficiencies.

Understanding substrate specificity is crucial for elucidating enzymatic mechanisms, designing drugs that target specific enzymes or pathways, and developing biotechnological applications that rely on the controlled manipulation of enzyme activities.

Thymine nucleotides are biochemical components that play a crucial role in the structure and function of DNA (deoxyribonucleic acid), which is the genetic material present in living organisms. A thymine nucleotide consists of three parts: a sugar molecule called deoxyribose, a phosphate group, and a nitrogenous base called thymine.

Thymine is one of the four nucleobases in DNA, along with adenine, guanine, and cytosine. It specifically pairs with adenine through hydrogen bonding, forming a base pair that is essential for maintaining the structure and stability of the double helix. Thymine nucleotides are linked together by phosphodiester bonds between the sugar molecules of adjacent nucleotides, creating a long, linear polymer known as a DNA strand.

In summary, thymine nucleotides are building blocks of DNA that consist of deoxyribose, a phosphate group, and the nitrogenous base thymine, which pairs with adenine in the double helix structure.

Acid anhydride hydrolases are a class of enzymes that catalyze the hydrolysis (breakdown) of acid anhydrides, which are chemical compounds formed by the reaction between two carboxylic acids. This reaction results in the formation of a molecule of water and the release of a new carboxylic acid.

Acid anhydride hydrolases play important roles in various biological processes, including the metabolism of lipids, carbohydrates, and amino acids. They are also involved in the regulation of intracellular pH and the detoxification of xenobiotics (foreign substances).

Examples of acid anhydride hydrolases include esterases, lipases, and phosphatases. These enzymes have different substrate specificities and catalytic mechanisms, but they all share the ability to hydrolyze acid anhydrides.

The term "acid anhydride hydrolase" is often used interchangeably with "esterase," although not all esterases are capable of hydrolyzing acid anhydrides.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Adenosine Triphosphate (ATP) is a high-energy molecule that stores and transports energy within cells. It is the main source of energy for most cellular processes, including muscle contraction, nerve impulse transmission, and protein synthesis. ATP is composed of a base (adenine), a sugar (ribose), and three phosphate groups. The bonds between these phosphate groups contain a significant amount of energy, which can be released when the bond between the second and third phosphate group is broken, resulting in the formation of adenosine diphosphate (ADP) and inorganic phosphate. This process is known as hydrolysis and can be catalyzed by various enzymes to drive a wide range of cellular functions. ATP can also be regenerated from ADP through various metabolic pathways, such as oxidative phosphorylation or substrate-level phosphorylation, allowing for the continuous supply of energy to cells.

Dideoxynucleotides are analogs of nucleotides, which are the building blocks of DNA and RNA. In a nucleotide, there is a sugar molecule (deoxyribose in DNA and ribose in RNA) attached to a phosphate group and one of four nitrogenous bases (adenine, guanine, cytosine, or thymine in DNA; adenine, guanine, cytosine, or uracil in RNA).

In a dideoxynucleotide, there are two fewer oxygen molecules on the sugar component. Specifically, instead of having a hydroxyl group (-OH) at both the 2' and 3' carbons of the sugar, a dideoxynucleotide has a hydrogen atom (-H) at the 3' carbon and a hydroxyl or another group at the 2' carbon.

Dideoxynucleotides are used in scientific research and medical diagnostics, most notably in the Sanger method of DNA sequencing. In this process, DNA polymerase adds nucleotides to a single-stranded DNA template during replication. When a dideoxynucleotide is incorporated into the growing DNA chain, it acts as a terminator because there is no 3' hydroxyl group for the next nucleotide to be added. By running multiple reactions with different dideoxynucleotides and comparing the lengths of the resulting DNA fragments, researchers can determine the sequence of the template DNA.

Dideoxynucleotides are also used as antiretroviral drugs in the treatment of HIV infection. They inhibit the reverse transcriptase enzyme that HIV uses to convert its RNA genome into DNA, thus preventing the virus from replicating. Examples of dideoxynucleoside analog reverse transcriptase inhibitors (ddNRTIs) include zidovudine (AZT), didanosine (ddI), stavudine (d4T), and lamivudine (3TC).

Nucleoside deaminases are a group of enzymes that catalyze the removal of an amino group (-NH2) from nucleosides, converting them to nucleosides with a modified base. This modification process is called deamination. Specifically, these enzymes convert cytidine and adenosine to uridine and inosine, respectively. Nucleoside deaminases play crucial roles in various biological processes, including the regulation of gene expression, immune response, and nucleic acid metabolism. Some nucleoside deaminases are also involved in the development of certain diseases and are considered as targets for drug design and discovery.

Hypoxanthine is a purine derivative and an intermediate in the metabolic pathways of nucleotide degradation, specifically adenosine to uric acid in humans. It is formed from the oxidation of xanthine by the enzyme xanthine oxidase. In the body, hypoxanthine is converted to xanthine and then to uric acid, which is excreted in the urine. Increased levels of hypoxanthine in the body can be indicative of various pathological conditions, including tissue hypoxia, ischemia, and necrosis.

Stavudine is an antiviral medication used to treat HIV (human immunodeficiency virus) infections. It works by blocking the action of reverse transcriptase, an enzyme that the virus needs to multiply. By preventing the multiplication of the virus, Stavudine helps reduce the amount of HIV in the body and slows down the progression of the disease.

Stavudine is often prescribed in combination with other antiretroviral drugs as part of a highly active antiretroviral therapy (HAART) regimen. It is available in oral form, typically taken twice daily, and is usually prescribed at a dose of 40 milligrams per dose for adults.

It's important to note that Stavudine can cause serious side effects, including peripheral neuropathy (nerve damage that causes pain, numbness, or tingling in the hands and feet), pancreatitis (inflammation of the pancreas), and lipoatrophy (loss of fat tissue under the skin). As a result, it is generally only prescribed when other antiretroviral drugs are not effective or tolerated.

If you have any questions about Stavudine or your HIV treatment regimen, be sure to talk with your healthcare provider.

Guanine is not a medical term per se, but it is a biological molecule that plays a crucial role in the body. Guanine is one of the four nucleobases found in the nucleic acids DNA and RNA, along with adenine, cytosine, and thymine (in DNA) or uracil (in RNA). Specifically, guanine pairs with cytosine via hydrogen bonds to form a base pair.

Guanine is a purine derivative, which means it has a double-ring structure. It is formed through the synthesis of simpler molecules in the body and is an essential component of genetic material. Guanine's chemical formula is C5H5N5O.

While guanine itself is not a medical term, abnormalities or mutations in genes that contain guanine nucleotides can lead to various medical conditions, including genetic disorders and cancer.

Biological transport refers to the movement of molecules, ions, or solutes across biological membranes or through cells in living organisms. This process is essential for maintaining homeostasis, regulating cellular functions, and enabling communication between cells. There are two main types of biological transport: passive transport and active transport.

Passive transport does not require the input of energy and includes:

1. Diffusion: The random movement of molecules from an area of high concentration to an area of low concentration until equilibrium is reached.
2. Osmosis: The diffusion of solvent molecules (usually water) across a semi-permeable membrane from an area of lower solute concentration to an area of higher solute concentration.
3. Facilitated diffusion: The assisted passage of polar or charged substances through protein channels or carriers in the cell membrane, which increases the rate of diffusion without consuming energy.

Active transport requires the input of energy (in the form of ATP) and includes:

1. Primary active transport: The direct use of ATP to move molecules against their concentration gradient, often driven by specific transport proteins called pumps.
2. Secondary active transport: The coupling of the movement of one substance down its electrochemical gradient with the uphill transport of another substance, mediated by a shared transport protein. This process is also known as co-transport or counter-transport.

Deoxyguanosine is a chemical compound that is a component of DNA (deoxyribonucleic acid), one of the nucleic acids. It is a nucleoside, which is a molecule consisting of a sugar (in this case, deoxyribose) and a nitrogenous base (in this case, guanine). Deoxyguanosine plays a crucial role in the structure and function of DNA, as it pairs with deoxycytidine through hydrogen bonding to form a rung in the DNA double helix. It is involved in the storage and transmission of genetic information.

Nucleosides are glycosylamines that can be thought of as nucleotides without a phosphate group. A nucleoside consists simply of ... Arabinosyl nucleosides Nucleobase Salvage enzyme Synthesis of nucleosides Ramesh, Deepthi; Vijayakumar, Balaji Gowrivel; Kannan ... into nucleosides (such as thymidine) and phosphate. The nucleosides, in turn, are subsequently broken down in the lumen of the ... In a nucleoside, the anomeric carbon is linked through a glycosidic bond to the N9 of a purine or the N1 of a pyrimidine. ...
Nucleoside analogues are nucleosides that are structurally similar (analogous) to the nucleosides used in DNA and RNA synthesis ... A nucleoside triphosphate is a nucleoside containing a nitrogenous base bound to a 5-carbon sugar (either ribose or deoxyribose ... Nucleoside analogues may also be used to treat viral infections. For example, azidothymidine (AZT) is a nucleoside analogue ... Nucleoside triphosphates cannot be absorbed well, so all nucleoside triphosphates are typically made de novo. The synthesis of ...
... s (NTs) are a group of membrane transport proteins which transport nucleoside substrates like adenosine ... There are two known types of nucleoside transporters, concentrative nucleoside transporters (CNTs; SLC28) and equilibrative ... "Physiological and pharmacological roles of nucleoside transporter proteins". Nucleosides, Nucleotides & Nucleic Acids. 27 (6): ... Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD (February 2004). "The equilibrative nucleoside transporter family, ...
Carbocyclic nucleosides were originally limited to a five-membered ring system, matching the ring-size of the nucleosides; ... Carbocyclic nucleosides (also referred to as carbanucleosides) are nucleoside analogues in which a methylene group has replaced ... There are two approaches used in the synthesis of carbocyclic nucleosides. Linear approaches to chiral carbocyclic nucleosides ... Zhu XF (March 2000). "The latest progress in the synthesis of carbocyclic nucleosides". Nucleosides, Nucleotides & Nucleic ...
This enzyme is also called nucleoside N-ribosyltransferase. Koch AL (November 1956). "Some enzymes of nucleoside metabolism of ... In enzymology, a nucleoside ribosyltransferase (EC 2.4.2.5) is an enzyme that catalyzes the chemical reaction D-ribosyl-base1 ... The systematic name of this enzyme class is nucleoside:purine(pyrimidine) D-ribosyltransferase. ...
Lysidine is an uncommon nucleoside, rarely seen outside of tRNA. It is a derivative of cytidine in which the carbonyl is ... Sonawane, Kailas D.; Tewari, Ravindra (19 September 2008). "Conformational Preferences of Hypermodified Nucleoside Lysidine ( ... k2C) Occurring at 'Wobble' Position in Anticodon Loop of tRNAIle". Nucleosides, Nucleotides & Nucleic Acids. 27 (10-11): 1158- ...
... (EC 1.1.3.28) is an enzyme with systematic name nucleoside:oxygen 5'-oxidoreductase. This enzyme catalyses ... Nucleoside+oxidase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology (EC 1.1.3). ... Isono Y, Sudo T, Hoshino M (1989). "Purification and reaction of a new enzyme, nucleoside oxidase". Agric. Biol. Chem. 53: 1663 ... Isono Y, Sudo T, Hoshino M (1989). "Properties of a new enzyme, nucleoside oxidase, from Pseudomonas maltophilia LB-86". Agric ...
Other names in common use include nucleoside triphosphate phosphohydrolase, nucleoside-5-triphosphate phosphohydrolase, and ... In enzymology, a nucleoside-triphosphatase (NTPase) (EC 3.6.1.15) is an enzyme that catalyzes the chemical reaction NTP + H2O ... LEWIS M, WEISSMAN S (1965). "Properties of a soluble nucleoside triphosphatase activity in mammalian liver". Arch. Biochem. ... Matsushita S, Raacke ID (1968). "Purification of nucleoside triphosphatases from pea seedling ribosomes". Biochim. Biophys. ...
In enzymology, a nucleoside phosphotransferase (EC 2.7.1.77) is an enzyme that catalyzes the chemical reaction a nucleotide + a ... The systematic name of this enzyme class is nucleotide:nucleoside 5'-phosphotransferase. Other names in common use include ... Prasher DC, Carr MC, Ives DH, Tsai TC, Frey PA (1982). "Nucleoside phosphotransferase from barley. Characterization and ... Brunngraber EF, Chargaff E (1967). "Purification and properties of a nucleoside phosphotransferase from carrot". J. Biol. Chem ...
... s are structural analogues of a nucleoside, which normally contain a nucleobase and a sugar. Nucleotide ... so it is possible to design nucleoside analogues that are preferentially incorporated by the former. Some nucleoside analogues ... Since nucleoside analogues require two phosphorylations to be activated, one carried out by a viral enzyme and the other by ... Nucleoside and nucleotide analogues can be used in therapeutic drugs, including a range of antiviral products used to prevent ...
... type B nucleoside diphosphatase, GDPase, CDPase, nucleoside 5'-diphosphatase, type L nucleoside diphosphatase, NDPase, and ... In enzymology, a nucleoside-diphosphatase (EC 3.6.1.6) is an enzyme that catalyzes the chemical reaction a nucleoside ... The systematic name of this enzyme class is nucleoside-diphosphate phosphohydrolase. Other names in common use include thiamine ... GIBSON DM, AYENGAR P, SANADI DR (1955). "A phosphatase specific for nucleoside diphosphates". Biochim. Biophys. Acta. 16 (4): ...
In enzymology, a nucleoside phosphoacylhydrolase (EC 3.6.1.24) is an enzyme that catalyzes the chemical reaction Hydrolyses ... Spahr PF, Gesteland RF (1970). "Purification and properties of a new enzyme from Escherichia coli: nucleoside phosphocyl ... The systematic name of this enzyme class is nucleoside-5'-phosphoacylate acylhydrolase. ...
... s are derivatives of natural or synthetic nucleosides. They are used to synthesize oligonucleotides, ... nucleosides modified at the 2'-position (OMe, protected NH2, F), nucleosides containing non-canonical bases (hypoxanthine and ... derivatives of nucleosides (nucleoside phosphoramidites) that serve as building blocks in phosphite triester methodology. To ... RO)2P-N(R1)2 + R2-N3 + H2O ---- (RO)2P(=O)-N(R1)2 + R2-NH2 + N2; The naturally occurring nucleotides (nucleoside-3'- or 5'- ...
... nucleoside trans-N-deoxyribosylase, trans-deoxyribosylase, trans-N-deoxyribosylase, trans-N-glycosidase, nucleoside ... nucleoside deoxyribosyltransferase II [purine(pyrimidine), and nucleoside:purine(pyrimidine) deoxyribosyltransferase]. This ... In enzymology, a nucleoside deoxyribosyltransferase (EC 2.4.2.6) is an enzyme that catalyzes the chemical reaction 2-deoxy-D- ... The systematic name of this enzyme class is nucleoside:purine(pyrimidine) deoxy-D-ribosyltransferase. Other names in common use ...
"Purification and characterization of purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase from Bacillus ... In enzymology, a pyrimidine-nucleoside phosphorylase (EC 2.4.2.2) is an enzyme that catalyzes the chemical reaction a ... The systematic name of this enzyme class is pyrimidine-nucleoside:phosphate alpha-D-ribosyltransferase. This enzyme is also ... Saunders PP, Wilson BA, Saunders GF (1969). "Purification and comparative properties of a pyrimidine nucleoside phosphorylase ...
The systematic name of this enzyme class is nucleoside-triphosphate diphosphohydrolase. This enzyme is also called nucleoside- ... In enzymology, a nucleoside-triphosphate diphosphatase (EC 3.6.1.19) is an enzyme that catalyzes the chemical reaction a ... Chern CJ, MacDonald AB, Morris AJ (1969). "Purification and properties of a nucleoside triphosphate pyrophosphohydrolase from ... the two substrates of this enzyme are nucleoside triphosphate and H2O, whereas its two products are nucleotide and diphosphate ...
... and functions as a substrate-specific channel for nucleosides and deoxy-nucleosides. The protein contains 294 amino acids, the ... Nucleoside-specific porin (the tsx gene of Escherichia coli) is an outer membrane protein, Tsx, which constitutes the receptor ... Bremer E, Martinussen J, Middendorf A, Valentin-Hansen P (1990). "Analysis of the tsx gene, which encodes a nucleoside-specific ...
In enzymology, a nucleoside-phosphate kinase (EC 2.7.4.4) is an enzyme that catalyzes the chemical reaction ATP + nucleoside ... the two substrates of this enzyme are ATP and nucleoside monophosphate, whereas its two products are ADP and nucleoside ... This enzyme is also called NMP-kinase, or nucleoside-monophosphate kinase. A number of crystal structures have been solved for ... Nucleoside monophosphate binding induces further changes that render the enzyme catalytically capable of facilitating a ...
SLC28A1 is a Na+-dependent nucleoside transporter selective for pyrimidine nucleosides and adenosine. It also transports the ... Human concentrative nucleoside transporters include SLC28A1, SLC28A2 and SLC28A3 proteins. SLC28A2 is a purine-specific Na+- ... nucleoside cotransporter". The Journal of Biological Chemistry. 270 (23): 13596-9. doi:10.1074/jbc.270.23.13596. PMID 7775409. ... "Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein". The Journal of ...
Nucleoside phosphorylase is an enzyme which cleaves a nucleoside by phosphorylating the ribose to produce a nucleobase and ... Purine nucleoside phosphorylase, PNP, PNPase or inosine phosphorylase (EC 2.4.2.1) is an enzyme that in humans is encoded by ... Purine nucleoside phosphorylase deficiency Canduri F, dos Santos DM, Silva RG, Mendes MA, Basso LA, Palma MS, de Azevedo WF, ... Borgers M, Verhaegen H, De Brabander M, De Cree J, De Cock W, Thoné F, Geuens G (Nov 1978). "Purine nucleoside phosphorylase in ...
Nucleoside diphosphate kinase activity involves the transfer of the γ-phosphate of nucleoside triphosphate (NTP) to nucleoside ... Nucleoside Nucleotide Nucleoside monophosphate Nucleoside triphosphate Thymidine kinase Thymidylate kinase Thymidine kinase in ... Nucleoside-diphosphate kinases (NDPKs, also NDP kinase, (poly)nucleotide kinases and nucleoside diphosphokinases) are enzymes ... Nucleoside-Diphosphate+Kinase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) EC 2.7.4.6 Portal: ...
Solute carrier family Equilibrative nucleoside transporters Nucleoside transporters Augustine blood group system GRCh38: ... Nucleoside transporters are required for nucleotide synthesis in cells that lack de novo nucleoside synthesis pathways, and are ... "A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and ... Equilibrative nucleoside transporter 1 (ENT1) is a protein that in humans is encoded by the SLC29A1 gene. Multiple ...
Mangravite LM, Badagnani I, Giacomini KM (2004). "Nucleoside transporters in the disposition and targeting of nucleoside ... Solute carrier family Equilibrative nucleoside transporters Nucleoside transporters GRCh38: Ensembl release 89: ENSG00000174669 ... Equilibrative nucleoside transporter 2 (ENT2) is a protein that in humans is encoded by the SLC29A2 gene. ... 2004). "The equilibrative nucleoside transporter family, SLC29". Pflügers Arch. 447 (5): 735-43. doi:10.1007/s00424-003-1103-2 ...
In enzymology, a diphosphate-purine nucleoside kinase (EC 2.7.1.143) is an enzyme that catalyzes the chemical reaction ... The systematic name of this enzyme class is diphosphate:purine nucleoside phosphotransferase. This enzyme is also called ... Tryon VV, Pollack D (1984). "Purine metabolism in Acholeplasma laidlawii B: novel PPi-dependent nucleoside kinase activity". J ... Tryon VV, Pollack JD (1985). "Distinctions in Mollicutes purine metabolism: pyrophosphate-dependent nucleoside kinase and ...
Concentrative nucleoside transporters Nucleoside transporters Solute carrier family GRCh38: Ensembl release 89: ENSG00000156222 ... 2004). "Transport of physiological nucleosides and anti-viral and anti-neoplastic nucleoside drugs by recombinant Escherichia ... Concentrative nucleoside transporter 1 (CNT1) is a protein that in humans is encoded by the SLC28A1 gene. ... 2004). "Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced ...
Concentrative nucleoside transporters Nucleoside transporters Solute carrier family GRCh38: Ensembl release 89: ENSG00000137860 ... "Molecular determinants of specificity for synthetic nucleoside analogs in the concentrative nucleoside transporter, CNT2". J. ... Concentrative nucleoside transporter 2 (CNT2) is a protein that in humans is encoded by the SLC28A2 gene. ... Wang J, Su SF, Dresser MJ, Schaner ME, Washington CB, Giacomini KM (Feb 1998). "Na(+)-dependent purine nucleoside transporter ...
... (EC 1.1.3.39) is an enzyme with systematic name nucleoside:oxygen 5'-oxidoreductase (H2O2- ... Nucleoside+oxidase+(H2O2-forming) at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology (EC ... Koga S, Ogawa J, Cheng L, Choi Y, Yamada H, Shimizu S (November 1997). "Nucleoside Oxidase, a Hydrogen Peroxide-Forming Oxidase ...
Nucleoside (in) Concentrative nucleoside transporter Nucleoside transporter Molina-Arcas M, Trigueros-Motos L, Casado FJ, ... Pastor-Anglada M (Jun 2008). "Physiological and pharmacological roles of nucleoside transporter proteins". Nucleosides, ... Young, J. D.; Yao, S. Y. M.; Sun, L.; Cass, C. E.; Baldwin, S. A. (2008-07-01). "Human equilibrative nucleoside transporter ( ... Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD (Feb 2004). "The equilibrative nucleoside transporter family, SLC29". ...
In enzymology, a (deoxy)nucleoside-phosphate kinase (EC 2.7.4.13) is an enzyme that catalyzes the chemical reaction ATP + ...
... in which some nucleosides are replaced by other naturally modified nucleosides or by synthetic nucleoside analogues. modRNA is ... and uridine nucleosides - the resulting mRNA is described as nucleoside-modified. Production of protein begins with assembly of ... June 2018). "Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses". The ... For example, uridine can be replaced with a similar nucleoside such as pseudouridine (Ψ) or N1-methyl-pseudouridine (m1Ψ), and ...
Nucleosides are glycosylamines that can be thought of as nucleotides without a phosphate group. A nucleoside consists simply of ... Arabinosyl nucleosides Nucleobase Salvage enzyme Synthesis of nucleosides Ramesh, Deepthi; Vijayakumar, Balaji Gowrivel; Kannan ... into nucleosides (such as thymidine) and phosphate. The nucleosides, in turn, are subsequently broken down in the lumen of the ... In a nucleoside, the anomeric carbon is linked through a glycosidic bond to the N9 of a purine or the N1 of a pyrimidine. ...
PURINE NUCLEOSIDE PHOSPHORYLASE1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN-9-YL)-D-RIBITOLMAGNESIUM IONPHOSPHATE ION ...
... and the other is purine nucleoside phosphorylase (PNP) deficiency, which i... ... encoded search term (Purine Nucleoside Phosphorylase Deficiency) and Purine Nucleoside Phosphorylase Deficiency What to Read ... Novel mutations and hot-spots in patients with purine nucleoside phosphorylase deficiency. Nucleosides Nucleotides Nucleic ... Purine Nucleoside Phosphorylase Deficiency. Updated: Aug 07, 2019 * Author: Alan P Knutsen, MD; Chief Editor: Harumi Jyonouchi ...
Nucleosides, Nucleotides and Nucleic Acids Publication Information. Title. Nucleosides, Nucleotides and Nucleic Acids [English] ...
GS-5734 is a monophosphate prodrug of an adenosine nucleoside analog that showed therapeutic efficacy in a non-human primate ... GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses Sci Rep. 2017 Mar 6;7:43395. doi: 10.1038/ ... GS-5734 is a monophosphate prodrug of an adenosine nucleoside analog that showed therapeutic efficacy in a non-human primate ... Here we report the antiviral activities of GS-5734 and the parent nucleoside analog across multiple virus families, providing ...
... called Protein Nucleoside 2-deoxyribosyltransferase from c.23.14.1: Nucleoside 2-deoxyribosyltransferase. *Protein Nucleoside 2 ... Timeline for Protein Nucleoside 2-deoxyribosyltransferase from c.23.14.1: N-deoxyribosyltransferase: *Protein Nucleoside 2- ... Nucleoside 2-deoxyribosyltransferase in SCOP 1.65. *Protein Nucleoside 2-deoxyribosyltransferase from c.23.14.1: N- ... Lineage for Protein: Nucleoside 2-deoxyribosyltransferase. *Root: SCOP 1.67 *. Class c: Alpha and beta proteins (a/b) [51349] ( ...
Crystal structure of Staphylococcus aureus nucleoside diphosphate kinase complexed with UDP ... Nucleoside diphosphate kinases (NDK) are characterized by high catalytic turnover rates and diverse substrate specificity. ... Conformational basis for substrate recognition and regulation of catalytic activity in Staphylococcus aureus nucleoside di- ... Crystal structure of Staphylococcus aureus nucleoside diphosphate kinase complexed with UDP. *PDB DOI: https://doi.org/10.2210/ ...
Nucleoside antagonist. Inhibits NF-κB signaling. Achieve your results faster with highly validated, pure and trusted compounds. ...
Nucleoside polyphosphates and their conjugates, such as nucleoside triphosphates, nucleoside tetraphosphates, sugar nucleotides ... Instead nucleoside 2,3-cyclic phosphates were obtained in good yield with the ribonucleoside substrates. This represents a ... The procedure is rapid, produces a wide variety of nucleoside polyphosphates and their conjugates in high yield, does not ... Attempts to prepare nucleoside triphosphates by subjecting unprotected ribonucleosides and 2-deoxyribonucleosides to activated ...
Deoxyuridine nucleosides embodied into diarylethenes form an especial class of photoswitchable compounds that are designed to ... Ultrafast Ring Closing of a Diarylethene-Based Photoswitchable Nucleoside. By Yang Li, Jose Luis Perez Lustres, Hans Robert ... Home / KnowledgeBase Articles / Ultrafast Ring Closing of a Diarylethene-Based Photoswitchable Nucleoside ...
Non-nucleoside Reverse Transcriptase Inhibitors. The definition of "adolescent" may differ depending on the regimen; for ... Nucleoside/Nucleotide Reverse Transcriptase Inhibitors. The definition of "adolescent" may differ depending on the regimen; for ... When given with nucleoside reverse transcriptase inhibitors, ENF, TPV/RTV, NVP, raltegravir (RAL), and drugs that are not ...
Novel Point-of-Care Diagnostic Method for Neonatal Encephalopathy Using Purine Nucleosides. Edward Beamer1,2† Mary Isabel ODea ... Purinergic signaling, characterized as a complex regulatory system governed by purine nucleotides such as ATP and nucleosides, ... In summary, this study demonstrates that blood purine nucleoside concentrations are increased following NE and have potential ... Thauerer, B., Zur Nedden, S., and Baier-Bitterlich, G. (2012). Purine nucleosides: endogenous neuroprotectants in hypoxic brain ...
Methylthioadenosine Nucleoside Transition State Analogs Show Potent In vitro and In vivo Activity Against Giardia intensinalis ... "Methylthioadenosine Nucleoside Transition State Analogs Show Potent In vitro and In vivo Activity Against Giardia intensinalis ...
... ... The mechanism of HBV resistance to nucleoside analogs are described as well as the concept for multiple drug therapy and ...
You are here: Nucleotides & Nucleosides , Nucleotides by Application , ... on DNA , Sequencing & SNP Genotyping , Unmodified ... Unmodified dideoxy-Nucleoside triphosphates (ddNTPs) - Bundles. Dideoxynucleotide triphosphates (ddNTPs) lack the 3-OH group ...
Fluorescently labeled dideoxy-Nucleoside triphosphates (ddNTPs). Single nucleotide polymorphisms (SNPs) are single base pair ... You are here: Nucleotides & Nucleosides , Nucleotides by Application , ... on DNA , Sequencing & SNP Genotyping , Fluorescently ...
Trichomonas vaginalis purine nucleoside phosphorylase (Trichomonas vaginalis). Find diseases associated with this biological ...
Cookie Policy This website uses cookies to ensure proper functionality of the shopping cart and checkout progress. By continuing to browse the site you are agreeing to the use of cookies. Click here to learn about cookie settings. Close ...
Fluorescent Nucleosides (2 suppliers). Fluorescent Particles (2 suppliers). Fluorescent Peptidase Substrates (4 suppliers). ...
Nucleobases, nucleosides, and nucleotides,state=autocollapse}}. *. {{navbar}}. , {{sidebar}}. , അഥവാ ഉള്ളടക്കം മറയ്ക്കാൻ നിർ ... Nucleobases, nucleosides, and nucleotides,state=expanded}}. ഈ ഫലകത്തിന്റെ ഉള്ളടക്കത്തെ എപ്പോഴും മുഴുവനായി കാണിക്കാൻ ഇങ്ങനെ ... Nucleobases, nucleosides, and nucleotides,state=collapsed}}. ഈ ഫലകത്തിന്റെ ഉള്ളടക്കത്തെ മറച്ചുവെച്ച് പ്രധാന തലക്കെട്ട് ... "https://ml.wikipedia.org/w/index.php?title=ഫലകം:Nucleobases,_nucleosides,_and_nucleotides&oldid=2111113" എന്ന താളിൽനിന്ന് ...
Nucleoside-modified messenger RNA (modRNA) is a modified form of mRNA that encodes the spike (S) glycoprotein of the SARS-CoV-2 ... How is RNA modified? Simply put, one of the four compounds in RNA is modified (e.g., the natural nucleoside uridine is modified ... modRNA (modified mRNA): modRNA is a man-made short-lived heterologous 5′-capped messenger RNA (mRNA), in which some nucleosides ... In the clinical trial for participants aged 12 through 15 who received the vaccine, which contains 30 mcg of nucleoside- ...
Author Summary The histiocytoses are a group of systemic disorders usually confined to childhood and are caused by an excessive number of histiocytes which phagocytose other cells and process antigens. Although nearly a century has passed since histiocytic disorders were recognised, their pathophysiology remains largely unclear, and treatment is nonspecific. The identification of SLC29A3 mutations as the molecular basis for a familial form of syndromic histiocytosis (FHC/RDD) confirms a direct link between Faisalabad histiocytosis and Rosai-Dorfman disease and links these disorders to other SLC29A3-associated phenotypes.
Nucleoside Phosphonate Interactions with Multiple Organic Anion Transporters in Renal Proximal Tubule. David S. Miller ... Nucleoside Phosphonate Interactions with Multiple Organic Anion Transporters in Renal Proximal Tubule. David S. Miller ... Nucleoside Phosphonate Interactions with Multiple Organic Anion Transporters in Renal Proximal Tubule. David S. Miller ... Nucleoside Phosphonate Interactions with Multiple Organic Anion Transporters in Renal Proximal Tubule ...
News stories and articles referencing nucleoside/nucleotide analogue therapy on European Pharmaceutical Review ... an antisense oligonucleotide therapy aided in long-term prevention of chronic hepatitis B in patients on and not on nucleoside/ ...
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Travis K. Warren,,SUP,1,/SUP,,SUP ... Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430 April 16, 2014, 02:38 PM. ... Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. ...
Nucleosides and Ribonucleosides for MEM-alpha (500X) complete media formulation available at Biological Industries ...
Synthesis of N,O-nucleosides via an Ene Reaction. Paolo Quadrelli presents the synthesis of N,O-nucleosides from ( ... The importance of nucleoside analogues. in a number of areas of drug discovery and chemical biology continues to act as a spur ... N,O-Nucleosides. from Ene Reaction of (Nitrosocarbonyl)mesitylene with Crotyl Alcohol: Selectivity, Scope, and Limitations: S. ...
Through mathematical modeling, we assess the mechanisms by which HIV-1 can develop resistance against nucleoside analog reverse ... Author Summary Nucleoside analogs (NAs) represent an important drug class for the treatment of viral infections and cancer. ... natural nucleosides has been produced, but where the last nucleoside in the chain is a chain-terminating . At each state , the ... prolonged with a nucleoside (polymerase reaction ) or -terminated by a nucleoside analog (reaction ). If the chain has been ...
Recent advances in synthetic approaches for medicinal chemistry of C-nucleosides ... Pfeiffer, M.; Nidetzky, B. Biocatalytic cascade transformations for the synthesis of C-nucleosides and N-nucleoside analogs. ... Roy, V.; Agrofoglio, L. A. Nucleosides and emerging viruses: A new story. Drug discovery today 2022, 27, 1945-1953. doi:10.1016 ... Mukhin, E. M.; Savateev, K. V.; Rusinov, V. L. Approaches to the synthesis of heterocyclic C-nucleosides. Russian chemical ...
... a nucleoside reverse transcriptase (RT) inhibitor, is an antiretroviral agent which is potent against drug-resistant HIV ... 4-Ethynyl-2-deoxyadenosine (4-E-dA), a nucleoside reverse transcriptase (RT) inhibitor, is an antiretroviral agent which is ... 4-Ethynyl-2-deoxyadenosine (4-E-dA), a nucleoside reverse transcriptase (RT) inhibitor, is an antiretroviral agent which is ...
  • Nucleosides are glycosylamines that can be thought of as nucleotides without a phosphate group. (wikipedia.org)
  • Nucleosides can be produced from nucleotides de novo, particularly in the liver, but they are more abundantly supplied via ingestion and digestion of nucleic acids in the diet, whereby nucleotidases break down nucleotides (such as the thymidine monophosphate) into nucleosides (such as thymidine) and phosphate. (wikipedia.org)
  • They are administered as nucleosides since charged nucleotides cannot easily cross cell membranes. (wikipedia.org)
  • Nucleoside polyphosphates and their conjugates, such as nucleoside triphosphates, nucleoside tetraphosphates, sugar nucleotides, dinucleoside pyro- and higher order polyphosphates, 2',3'-cyclic nucleoside monophosphates, and 2´-deoxynucleoside-5´-tetraphosphates in which a fluorescent label is attached to the terminal phosphate have many biological roles and have been developed into drugs. (uwaterloo.ca)
  • Poster session presented at RSC Symposium on Nucleosides and Nucleotides: synthetic and biological chemistry, London, United Kingdom. (qub.ac.uk)
  • In medicine several nucleoside analogues are used as antiviral or anticancer agents. (wikipedia.org)
  • Due to the low stability of RNA, which is prone to hydrolysis, several more stable alternative nucleoside/nucleotide analogues that correctly bind to RNA are used. (wikipedia.org)
  • Bepirovirsen, an antisense oligonucleotide therapy aided in long-term prevention of chronic hepatitis B in patients on and not on nucleoside/nucleotide analogues in a Phase II trial. (europeanpharmaceuticalreview.com)
  • The importance of nucleoside analogues in a number of areas of drug discovery and chemical biology continues to act as a spur to develop practical and efficient synthetic methods for accessing these compounds. (thieme.de)
  • Rauter, A. P. Nucleoside analogues: N-glycosylation methodologies, synthesis of antiviral and antitumor drugs and potential against drug-resistant bacteria and Alzheimer's disease. (beilstein-journals.org)
  • Continued interest in imino-sugar nucleosides derives from the observations that N-ribosyltransferases are powerfully inhibited by imino-C-nucleoside analogues that mimic the ribooxacarbenium ion nature of their transition states. (elsevierpure.com)
  • The synthesis of such compounds is challenging, and synthetic routes to imino- and imino-C-nucleosides are reviewed, together with the nature of the N-ribosyltransferases that are targets for these analogues. (elsevierpure.com)
  • Explore our uniquely large collection of reagents that contains popular nucleoside building blocks, nucleosides that facilitate epigenetics research and a family of pseudouridine analogues. (biosearchtech.com)
  • The mechanism of HBV resistance to nucleoside analogs are described as well as the concept for multiple drug therapy and combination with immunostimulatory approaches. (nih.gov)
  • Nucleoside analogs ( NA s) are used to treat numerous viral infections and cancer. (plos.org)
  • Nucleoside analogs ( NA s) represent an important drug class for the treatment of viral infections and cancer. (plos.org)
  • von Kleist M, Metzner P, Marquet R, Schütte C (2012) HIV-1 Polymerase Inhibition by Nucleoside Analogs: Cellular- and Kinetic Parameters of Efficacy, Susceptibility and Resistance Selection. (plos.org)
  • Nidetzky, B. Biocatalytic cascade transformations for the synthesis of C-nucleosides and N-nucleoside analogs. (beilstein-journals.org)
  • CONCLUSION: Combination antiretroviral therapy during pregnancy with two nucleoside analogs was well-tolerated by mothers and newborns, with no significant short-term toxicities or side effects noted. (jefferson.edu)
  • macologic classes: nucleoside analogs, interferons, The aim of this study was to investigate whether a panel protease inhibitors, reverse transcriptase inhibitors, and of currently available antiviral agents exhibit in vitro neuraminidase inhibitors. (cdc.gov)
  • Several novel and efficient approaches to the synthesis of nucleoside polyphosphates and their conjugates were developed. (uwaterloo.ca)
  • Finally an entirely new approach to the synthesis of nucleoside tetraphosphates (Np4's), dinucleoside pentaphosphates (Np5N's) and nucleoside tetraphosphates in which a fluorescent dye is attached to the terminal phosphate is described employing an activated form of cyclic trimetaphosphate as a novel phosphorylating agent. (uwaterloo.ca)
  • Paolo Quadrelli presents the synthesis of N,O-nucleosides from (nitrosocarbonyl)mesitylene. (thieme.de)
  • Rusinov, V. L. Approaches to the synthesis of heterocyclic C-nucleosides. (beilstein-journals.org)
  • Banerjee, S. Efficient synthesis of novel 2-deoxy-C-nucleosides containing oxa and thiadiazole derivatives and their biological activity. (beilstein-journals.org)
  • Nucleosides are precursors for nucleic acid synthesis and are essential for metabolism and cell growth. (biosearchtech.com)
  • We offer over 300 nucleosides, precursors, and reagents to synthesise nucleosides and make them incorporation-ready for oligo synthesis. (biosearchtech.com)
  • Use our reagents to generate reactive nucleosides for oligo synthesis. (biosearchtech.com)
  • A convenient selective synthesis of 2′,3′-di-O-acetyl-nucleo- tide-5′-phosphates, 2′,3′-di-O-acetyl-nucleotide-5′-triphosphates and 2′,3′,5′-tri-O-acetyl-nucleosides in water has been developed. (ucl.ac.uk)
  • Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (umassmed.edu)
  • This graph shows the total number of publications written about "Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins" by people in this website by year, and whether "Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins" was a major or minor topic of these publications. (umassmed.edu)
  • Below are the most recent publications written about "Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins" by people in Profiles. (umassmed.edu)
  • The nucleosides, in turn, are subsequently broken down in the lumen of the digestive system by nucleosidases into nucleobases and ribose or deoxyribose. (wikipedia.org)
  • [ 2 , 3 ] One disorder is adenosine deaminase (ADA) deficiency, which is Online Mendelian Inheritance in Man (OMIM) subject number 102700, and the other is purine nucleoside phosphorylase (PNP) deficiency, which is OMIM subject number 164050. (medscape.com)
  • In both adenosine deaminase and purine nucleoside phosphorylase deficiencies, thymocytes are thought to be selectively destroyed because of elevated levels of dATP and dGTP. (medscape.com)
  • GS-5734 is a monophosphate prodrug of an adenosine nucleoside analog that showed therapeutic efficacy in a non-human primate model of Ebola virus infection. (nih.gov)
  • Adenosine signaling is terminated by its uptake through equilibrative nucleoside transporters (ENTs). (ozgene.com)
  • Since the equilibrative nucleoside transporter -2 (Ent2) is important in regulating brain adenosine homeostasis , the present study aimed to investigate the role of Ent2 in mice with cerebral ischemia - reperfusion . (bvsalud.org)
  • The procedure is rapid, produces a wide variety of nucleoside polyphosphates and their conjugates in high yield, does not require protection and subsequent deprotection of the nucleotide donors or acceptors and can be used to activate nucleoside mono-, di-, and triphosphates and a wide variety of acceptors. (uwaterloo.ca)
  • Attempts to prepare nucleoside triphosphates by subjecting unprotected ribonucleosides and 2'-deoxyribonucleosides to activated cyclic trimetaphosphate failed. (uwaterloo.ca)
  • The Critical Role of Equilibrative Nucleoside Transporter-2 in Modulating Cerebral Damage and Vascular Dysfunction in Mice with Brain Ischemia-Reperfusion. (bvsalud.org)
  • Here we report the antiviral activities of GS-5734 and the parent nucleoside analog across multiple virus families, providing evidence to support new indications for this compound against human viruses of significant public health concern. (nih.gov)
  • The interactions of two antiviral, acyclic nucleoside phosphonates, adefovir and cidofovir, with xenobiotic transporters was studied in intact killifish ( Fundulus heteroclitus ) renal proximal tubules by using fluorescent substrates, confocal microscopy, and quantitative image analysis. (aspetjournals.org)
  • Nucleoside diphosphate kinases (NDK) are characterized by high catalytic turnover rates and diverse substrate specificity. (rcsb.org)
  • In the first approach dinucleoside polyphosphates (NpnN's where n = 2-4) are prepared via in situ trifluoroacetate protection and imidazolium activation of nucleoside 5'-monophosphates. (uwaterloo.ca)
  • In the presence of Ca2+, NTPDase4 hydrolyzes nucleoside diphosphates UDP, GDP, CDP and dTDP to nucleoside monophosphates UMP, GMP, CMP and dTMP, respectively (Wang and Guidotti 1998). (reactome.org)
  • Nucleotide is a compound consisting of a nucleoside linked to a phosphate group. (broadpharm.com)
  • In purine nucleoside phosphorylase deficiency, similar changes occur, resulting in elevated deoxy-GTP (dGTP) levels. (medscape.com)
  • In a further description of the mechanism of T-cell depletion in purine nucleoside phosphorylase deficiency, Arpaia et al reported increased in vivo apoptosis of T cells and increased in vitro sensitivity to gamma irradiation in a murine model. (medscape.com)
  • [ 4 ] The immune deficiency in purine nucleoside phosphorylase deficiency may be the result of inhibited mitochondrial DNA repair due to the accumulation of dGTP in the mitochondria. (medscape.com)
  • Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors. (lu.se)
  • Diagnosis of purine nucleoside phosphorylase deficiency is by DNA analysis. (msdmanuals.com)
  • Treatment of purine nucleoside phosphorylase deficiency is with bone marrow or stem cell transplantation. (msdmanuals.com)
  • Phosphoramidite is a synthetic nucleoside derivative containing a phosphite ester group. (broadpharm.com)
  • Through mathematical modeling, we assess the mechanisms by which HIV-1 can develop resistance against nucleoside analog reverse transcriptase inhibitors (NRTI). (plos.org)
  • 4'-Ethynyl-2'-deoxyadenosine (4'-E-dA), a nucleoside reverse transcriptase (RT) inhibitor, is an antiretroviral agent which is potent against drug-resistant HIV variants, with an EC50 of 98 nM in MT-4 cells for anti-HIV-1 activity. (adooq.com)
  • Demographic, laboratory, and pregnancy outcome data were collected for 39 women whose antiretroviral treatment regimens were expanded to include more than one nucleoside analog for maternal indications. (jefferson.edu)
  • In a nucleoside, the anomeric carbon is linked through a glycosidic bond to the N9 of a purine or the N1 of a pyrimidine. (wikipedia.org)
  • These molecules permit the sequential addition of new bases to the chain in a highly efficient reaction, to avoid undesired side reactions, reactive hydroxy and exocyclic amino groups present in nucleosides are appropriately protected. (broadpharm.com)
  • Comparison of the inhibitory potencies of the nucleoside phosphonates with other substrates and inhibitors showed them to be moderate inhibitors of OAT1- and Mrp2-mediated transport. (aspetjournals.org)
  • Our model correctly predicts for HIV-1 that resistance against nucleoside analog reverse transcriptase inhibitors (NRTIs) can be conferred by decreasing their incorporation rate, increasing their excision rate, or decreasing their affinity for the polymerase enzyme. (plos.org)
  • Nucleoside reverse transcriptase inhibitors (NRTIs) block reverse transcriptase (an HIV enzyme). (hiv.gov)
  • Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine. (aspetjournals.org)
  • Incorporate fluorescent nucleosides into your oligo to observe the transition between DNA structural types. (biosearchtech.com)
  • Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy. (bmj.com)
  • METHODS: Samples of semen and blood were obtained from a cohort of 12 nucleoside reverse transcriptase inhibitor experienced men before and during 25-68 weeks of combination therapy, which included the protease inhibitor indinavir. (bmj.com)
  • CONCLUSIONS: These data show that stable reduction of blood and seminal fluid viral titres is not achievable in a significant proportion of nucleoside reverse transcriptase inhibitor experienced men. (bmj.com)
  • Initial multicenter experience with double nucleoside therapy for human immunodeficiency virus infection during pregnancy. (jefferson.edu)
  • LGC, Biosearch Technologies offers the largest range of specialised products for nucleosides on the market. (biosearchtech.com)
  • Deoxyuridine nucleosides embodied into diarylethenes form an especial class of photoswitchable compounds that are designed to stack and pair with DNA bases. (jascoinc.com)
  • Nucleoside-modified messenger RNA (modRNA) is a modified form of mRNA that encodes the spike (S) glycoprotein of the SARS-CoV-2 virus, the virus that causes COVID-19. (republicbroadcasting.org)
  • A nucleoside consists simply of a nucleobase (also termed a nitrogenous base) and a five-carbon sugar (ribose or 2'-deoxyribose) whereas a nucleotide is composed of a nucleobase, a five-carbon sugar, and one or more phosphate groups. (wikipedia.org)
  • Naismith, J. H. Experimental and computational snapshots of C-C bond formation in a C-nucleoside synthase. (beilstein-journals.org)